An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Terrestrial Bio, Inc. is hiring an EHS leader to own programs across two Greater Boston sites. You will professionalize safety, build scalable processes for lab and manufacturing, and ensure compliance with environmental, health, and safety regulations while supporting a new Allston facility.
You will drive risk reduction, training, and incident response, partnering with Manufacturing and Quality to integrate safety into everyday work. This is a hands-on role with growth into a larger program.
Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial's proprietary Tacterra™ microarray patch (MAP) and applicator platform consists of a patch resembling an adhesive bandage, which is applied with a preloaded applicator and removed after a few minutes. Once applied, each patch delivers bioactive tips into the skin, which dissolve quickly into the body, rapidly releasing their therapeutic payload. Designed for self-administration, the temperature-stable Tacterra™ platform enables precise, controlled delivery of a wide range of therapeutics without medical sharps or refrigeration.
Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial's proprietary Tacterra™ microarray patch (MAP) and applicator platform consists of a patch resembling an adhesive bandage, which is applied with a preloaded applicator and removed after a few minutes. Once applied, each patch delivers bioactive tips into the skin, which dissolve quickly into the body, rapidly releasing their therapeutic payload. Designed for self-administration, the temperature-stable Tacterra™ platform enables precise, controlled delivery of a wide range of therapeutics without medical sharps or refrigeration. Terrestrial has generated strong clinical and in-vivo proof of concept across multiple molecules. For more information, visit www.terrestrialbio.com. Most advanced therapeutics still require cold-chain logistics and clinical administration using needles. We are developing a needle-free Microneedle-Array Patch (MAP) delivery platform that enables up to two weeks of sustained delivery with only five minutes of wear-time. Delivering on that means running BSL-2 laboratories while standing up GMP manufacturing, on a compressed timeline and across a facility move. EHS foundations already exist here: annual training, biosafety and chemical hygiene practices, waste and vendor relationships, working documentation. We need someone to take them over and make them systematic, scalable, and audit-ready, treating safety as an operational advantage rather than a compliance checkbox.
You Will Own EHS Across Both Sites, Split Roughly Evenly Between Laboratory And Biosafety Programs And Manufacturing Safety Infrastructure. You Will Inherit Functioning Programs; Your Mandate Is To Professionalize And Extend Them